Neurotherapeutics as an Adjunctive Approach to Enhance Exposure Outcomes in Anxiety
1 other identifier
interventional
30
1 country
1
Brief Summary
Anxiety disorders are highly prevalent and costly to the individual and society. Exposure-based cognitive behavioral therapy (CBT) is the gold-standard intervention for anxiety disorders, although this approach does not fully reduce symptoms for all individuals. Therefore there is a need for innovative intervention approaches. One approach to augment and improve existing therapies would be to enhance the neurocognitive basis of fear extinction processes, which are the model on which treatments are based. Enhancing these processes may be possible through computerized cognitive training techniques which target executive functioning, the cognitive processes that help people manage complex cognitive activities. The proposed project is a proof-of-concept pilot study investigating the potential for training of executive functioning to improve anxiety-related outcomes. Individuals with elevated levels of social anxiety will be randomized to single-session COGnitive Enhancement Training (COGENT) or sham training program (ST). All participants will complete a single speech session where they present three 7-minute impromptu speeches and rate their anxiety at specific intervals. Participants will then complete the COGENT paradigm and affective processing task while undergoing fMRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2019
CompletedFirst Submitted
Initial submission to the registry
June 21, 2021
CompletedFirst Posted
Study publicly available on registry
July 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedOctober 1, 2021
September 1, 2021
1.8 years
June 21, 2021
September 30, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
BOLD activation during cognitive task
Working Memory Span task during fMRI
immediately after the intervention
BOLD activation during emotional task
Face processing task during fMRI
immediately after the intervention
Secondary Outcomes (1)
Speech anxiety ratings
baseline, ratings during 3 speeches
Study Arms (2)
Cognitive Training + exposure
EXPERIMENTALParticipants will complete adaptive computerized cognitive training plus a series of speech tasks
No training + exposure
ACTIVE COMPARATORParticipants will complete a low-dose computerized cognitive program plus a series of speech tasks
Interventions
Participants are asked to remember a series of items while solving puzzles.
Eligibility Criteria
You may qualify if:
- Screened positive for anxiety symptoms
- Between the ages of 18-55, inclusive.
- Have signed informed consent document(s) indicating that he/she understands the purpose of and procedures required for the study and is willing to participate in the study.
- Have sufficient proficiency in English language to understand and complete interviews, questionnaires, and all other study procedures.
You may not qualify if:
- Evidence of psychosis, bipolar disorder, or severe substance use disorder based on clinical cutoffs on self report measures
- Current neurological conditions based on brief medical history
- Current psychotherapy for anxiety or psychotropic medications
- MRI contraindications including: cardiac pacemaker, metal fragments in eyes/skin/body (shrapnel), aortic/aneurysm clips, prosthesis, by-pass surgery/coronary artery clips, hearing aid, heart valve replacement, shunt (ventricular or spinal), electrodes, metal plates/pins/screws/wires, or neuro/bio-stimulators (TENS unit), persons who have ever been a metal worker/welder, history of eye surgery/eyes washed out because of metal, vision problems uncorrectable with lenses, inability to lie still on one's back for 60 minutes; prior neurosurgery; tattoos with metal dyes, unwillingness to remove body piercings, and pregnancy.
- Active suicidal ideation endorsed on the depression self-report measure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC San Diego
San Diego, California, 92037, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 21, 2021
First Posted
July 8, 2021
Study Start
November 1, 2019
Primary Completion
September 1, 2021
Study Completion
September 1, 2021
Last Updated
October 1, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share